Chimerix reports excellent results from CMX157 Stage 1 clinical trial for HIV Chimerix.

Moch, Chief and President Executive Officer of Chimerix.’.. Chimerix reports excellent results from CMX157 Stage 1 clinical trial for HIV Chimerix, Inc., a pharmaceutical company developing orally-obtainable antiviral therapeutics, today announced first-in-human Phase 1 clinical trial results for CMX157 demonstrating a favorable safety, drug and tolerability distribution profile. Furthermore, results from a series of preclinical studies showed that CMX157 exhibited highly powerful in vitro activity against human being immunodeficiency virus , including HIV strains resistant to current treatments, and potent in vitro activity against xenotropic murine leukemia virus-related virus , a blood-borne retrovirus recently connected with chronic fatigue syndrome .D., Senior Director of Virology of Chimerix.’ ‘Our CMX001 and CMX157 programs are producing compelling clinical and preclinical evidence of how Chimerix’s PIM Conjugate Technology transforms the way compounds are absorbed, distributed, excreted and metabolized, creating new agents with improved antiviral action and reduced toxicities.Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a scheduled plan of the Kaiser Family members Foundation, a nonpartisan health care policy research firm unaffiliated with Kaiser Permanente.

Ariz. Delays Medicaid expansion decision, states make other health law implementation news Arizona Gov. The Associated Press/Arizona Republic: Brewer Decision On Medicaid Expected In January Gov. Jan Brewer evidently won’t say until January whether Arizona should expand the state’s Medicaid system under the federal health care overhaul. That’s the phrase from Brewer administration officials who briefed reporters on Thursday about financing and policy considerations becoming weighed by the governor, her personnel and agency officials . Texas Tribune: Video: Texans Worry About CHIP Amid HEALTHCARE Overhaul The Affordable Treatment Act requires states to maintain eligibility requirements for Medicaid and the Children’s MEDICAL HEALTH INSURANCE Program through 2019.